Table 2.
Spearman’s rank correlation of the hemoglobin levels and various clinical characteristics
| Hb | P | |
|---|---|---|
| Age | 0.035 | 0.101 |
| Tumor type | 0.014 | 0.509 |
| T stage | −0.078 | <0.001 |
| N stage | −0.051 | 0.019 |
| Clinical stage | −0.085 | <0.001 |
| Histologic grading | 0.010 | 0.653 |
| ER | 0.029 | 0.181 |
| PR | 0.016 | 0.460 |
| HER-2 | −0.035 | 0.103 |
| BMI | 0.134 | <0.001 |
| Chemotherapy | −0.025 | 0.242 |
| Radiotherapy | −0.014 | 0.521 |
| Hormonal therapy | 0.002 | 0.912 |
| Targeted therapy | −0.034 | 0.115 |
Abbreviations: Hb hemoglobin, ER estrogen receptor, PR progesterone receptor, HER-2 Human Epidermal Growth Factor Receptor-2, BMI body mass index.